Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, indicating a new revision of the page content. This change is a metadata-level patch rather than a substantive update to the study information.
    Difference
    0.0%
    Check dated 2026-04-30T18:28:11.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:24:18.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:02:46.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a system-level update with no visible changes to the study details on the page.
    Difference
    0.0%
    Check dated 2026-03-11T16:56:06.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    An administrative revision tag (v3.4.2) was added and previously displayed notices about government funding and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:04:17.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a government funding lapse notice banner. Updated the page revision tag from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:29:42.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.